In the earlier prospective cohort study of these two researchers on 57 patients, an association between increased hematoma fluid (but not serum) of a panel of biomarkers considered an anti-inflammatory index (IL-4, IL-5, IL-10, IL-13, IL-1 RA) and a reduced risk of recurrence was indicated [22]. This evidence concerns the gene IL5 and hematoma.